Specialist care at a distance: Patient-reported experience with telemedicine video consultations for neurological symptoms associated with post-COVID-19 condition or in temporal association with COVID-19 vaccination in a single-center retrospective cross-sectional study - Report - MDSpire
Advertisement
Specialist care at a distance: Patient-reported experience with telemedicine video consultations for neurological symptoms associated with post-COVID-19 condition or in temporal association with COVID-19 vaccination in a single-center retrospective cross-sectional study
Clinical Report: Patient Experiences with Telemedicine for Neurological Symptoms
Overview
This study evaluates patient-reported experiences with telemedicine video consultations (TVC) for neurological symptoms related to post-COVID-19 condition (PCC) and COVID-19 vaccination. It highlights the challenges faced by patients in accessing specialized care and the potential benefits of telemedicine in providing support and guidance.
Background
The COVID-19 pandemic has significantly accelerated the adoption of telemedicine, particularly for neurological care. Post-COVID-19 condition (PCC) affects a substantial number of individuals, leading to debilitating neurological symptoms that complicate access to traditional healthcare. Understanding patient experiences with telemedicine is crucial for optimizing care delivery in this context.
Data Highlights
No numerical data was provided in the source material.
Key Findings
Telemedicine video consultations (TVC) have become essential for maintaining continuity of care during the COVID-19 pandemic.
Patients with neurological symptoms related to PCC or COVID-19 vaccination face significant barriers to accessing in-person care.
The study included patients with documented SARS-CoV-2 infection or vaccination records, emphasizing the need for tailored care.
Patient-reported experiences with TVC were assessed to understand administrative, technical, and consultation-related aspects.
Both PCC and post-vaccination symptoms lack definitive biomarkers and treatments, complicating diagnosis and management.
Clinical Implications
Healthcare providers should consider integrating telemedicine into routine neurological care to enhance access for patients with PCC and vaccine-related symptoms. Understanding patient experiences can guide improvements in telehealth services and support better clinical outcomes.
Conclusion
Telemedicine presents a viable alternative for patients experiencing neurological symptoms post-COVID-19, addressing access challenges while highlighting the need for further research into patient experiences and outcomes.
